Art

J-GLOBAL ID：201602270408301687   Reference number：16A1069665

Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients

関節リウマチ患者における間質性肺疾患の進行に対するアバタセプトの有効性

Author (4)： Nakashita Tamao (Department of Rheumatology, Kameda Medical Center, 929 Higashi-Cho, Kamogawa-City, Chiba 296-8602, Japan) ,  Ando Katsutoshi (Division of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan) ,  Takahashi Kazuhisa (Division of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan) ,  Motojima Shinji (Department of Rheumatology, Kameda Medical Center, 929 Higashi-Cho, Kamogawa-City, Chiba 296-8602, Japan)
Material： Respiratory Investigation  (Respir Investig)
Volume： 54  Issue： 5  Page： 376-379  Publication year： Sep. 2016 
JST Material Number： W2316A  ISSN： 2212-5345  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *Lung Diseases, Interstitial

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A1069665&from=J-GLOBAL&jstjournalNo=W2316A") }}

JST classification (2)： Drug therapy(=pharmacotherapy)for respiratory system diseases  (GI05020J) ,  Treatment for immunologic diseases,allergic diseases.  (GD04030Y)

Substance index (1)： Orencia

Reference (9)：

• Vij R, Strek ME. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease. Chest 2013;143:814-24.
• Kameda H, Kanbe K, Sato E, et al. Continuation of metho-trexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week results from the JASMR study. J. Rheumatol. 2011;38:1585-92.
• Tanaka Y, Yamanaka H, Saito K, et al. Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept. Mod. Rheumatol. 2012;22:186-94.
• Roubille C, Haraoui B. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review. Semin. Arthritis Rheum. 2014;43:613-26.
• Nakashita T, Ando K, Kaneko N, et al. Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis. BMJ Open 2014;4:e005615.

Terms in the title (5)： 関節リウマチ ,  患者 ,  間質性肺疾患 ,  アバタセプト ,  有効性